Annual Total Liabilities
$25.96 M
-$134.16 M-83.79%
December 31, 2023
Summary
- As of February 7, 2025, ELVN annual total liabilities is $25.96 million, with the most recent change of -$134.16 million (-83.79%) on December 31, 2023.
- During the last 3 years, ELVN annual total liabilities has fallen by -$125.35 million (-82.84%).
- ELVN annual total liabilities is now -83.79% below its all-time high of $160.12 million, reached on December 31, 2022.
Performance
ELVN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$17.03 M
-$5.08 M-22.99%
September 30, 2024
Summary
- As of February 7, 2025, ELVN quarterly total liabilities is $17.03 million, with the most recent change of -$5.08 million (-22.99%) on September 30, 2024.
- Over the past year, ELVN quarterly total liabilities has dropped by -$8.04 million (-32.07%).
- ELVN quarterly total liabilities is now -89.37% below its all-time high of $160.12 million, reached on December 31, 2022.
Performance
ELVN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ELVN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -83.8% | -32.1% |
| 3 y3 years | -82.8% | +48.7% |
| 5 y5 years | -82.8% | +48.7% |
ELVN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -83.8% | at low | -89.4% | +79.1% |
| 5 y | 5-year | -83.8% | at low | -89.4% | +79.1% |
| alltime | all time | -83.8% | at low | -89.4% | +79.1% |
Enliven Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.03 M(-23.0%) |
| Jun 2024 | - | $22.11 M(-11.8%) |
| Mar 2024 | - | $25.07 M(-3.5%) |
| Dec 2023 | $25.96 M | $25.96 M(+111.2%) |
| Sep 2023 | - | $12.29 M(+29.3%) |
| Jun 2023 | - | $9.51 M(-17.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $11.45 M(-92.8%) |
| Dec 2022 | $160.12 M(+2.5%) | $160.12 M(+0.8%) |
| Sep 2022 | - | $158.89 M(+1.7%) |
| Dec 2021 | $156.22 M(+3.2%) | - |
| Dec 2021 | - | $156.22 M |
| Dec 2020 | $151.31 M | - |
FAQ
- What is Enliven Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics annual total liabilities year-on-year change?
- What is Enliven Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly total liabilities year-on-year change?
What is Enliven Therapeutics annual total liabilities?
The current annual total liabilities of ELVN is $25.96 M
What is the all time high annual total liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high annual total liabilities is $160.12 M
What is Enliven Therapeutics annual total liabilities year-on-year change?
Over the past year, ELVN annual total liabilities has changed by -$134.16 M (-83.79%)
What is Enliven Therapeutics quarterly total liabilities?
The current quarterly total liabilities of ELVN is $17.03 M
What is the all time high quarterly total liabilities for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly total liabilities is $160.12 M
What is Enliven Therapeutics quarterly total liabilities year-on-year change?
Over the past year, ELVN quarterly total liabilities has changed by -$8.04 M (-32.07%)